Projects

Trodelvy (sacituzumab govitecan) for the Treatment of Advanced Triple-Negative Breast Cancer

Trodelvy (sacituzumab govitecan-hziy) is the first approved antibody-drug conjugate for the treatment of advanced triple-negative breast cancer (TNBC) in adult …

FRUZAQLA (fruquintinib) for the Treatment of Metastatic Colorectal Cancer, USA

FRUZAQLA™ (fruquintinib) is a kinase inhibitor indicated to treat adults with metastatic colorectal cancer (mCRC). It is an oral treatment designed …

Lonsurf (trifluridine and tipiracil) for the Treatment of Refractory Metastatic Colorectal Cancer

Lonsurf (trifluridine and tipiracil) is an oral anti-cancer drug indicated for the treatment of patients with advanced metastatic colorectal cancer …

LUMAKRAS (sotorasib) for the Treatment of Non-Small Cell Lung Cancer

Lumakras (sotorasib) is an oral, first-in-class therapy indicated for the treatment of adult patients with KRAS G12C-mutated locally advanced or …

Loqtorzi for the Treatment of Nasopharyngeal Carcinoma, US

Loqtorzi (toripalimab-tpzi) is an immuno-oncology therapy indicated in combination with cisplatin and gemcitabine combination chemotherapy for the first-line treatment of …